N-Acetyl Epithalon Amidate
Research Goal: Assessing the activation of telomerase and the modulation of melatonin secretion through the pineal-hypothalamic axis with an acetylated/amidated derivative.
Route
Subcutaneous injection
Dose range
5 mg – 10 mg
Frequency
Once per day (subcutaneous)
Cycle length
10–20 days; typically repeated only once or twice per year
Overview
Research Goal: Assessing the activation of telomerase and the modulation of melatonin secretion through the pineal-hypothalamic axis with an acetylated/amidated derivative.
Preparation: Reconstitute with 2.0 mL bacteriostatic water. The acetylated form offers higher resistance to enzymatic degradation.
Studied benefits
- An advanced, more stable version of Epithalon with improved bioavailability
- It focuses on telomere maintenance, pineal gland health, and anti-aging at the cellular level, helping to regulate the body's internal clock and immune response
Reported side effects
- Very high safety profile
- side effects are rare and typically limited to minor irritation at the injection site
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Phase | Daily Dose (mg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Standard Cycle | 5.0 mg | 200 units (2 mL) | + Log |
| High-Intensity Pulse | 10.0 mg | 400 units (4 mL) | + Log |
Frequency
Once per day (subcutaneous).
Timing
Evening administration to align with circadian rhythms.
Cycle length
10–20 days; typically repeated only once or twice per year.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
1 doses of 5 mg per vial
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Maintain a nutrient-dense diet and practice caloric restriction to support the anti-aging and telomere-lengthening signaling promoted by this more bioavailable version of Epithalon. Stay physically active to maintain cellular resilience and metabolic health throughout the research cycle. Ensure 7–9 hours of sleep in total darkness to maximize the endogenous melatonin production that works in parallel with the peptide’s action on the pineal gland. Practice consistent stress management to minimize oxidative stress and protect chromosomal integrity from premature shortening caused by chronic cortisol elevation.
Evidence
Research summaries
Overview of Epitalon—Highly Bioactive Pineal Tetrapeptide with Promising Anti-Aging Properties
Findings: Resets cellular aging clocks, extends lifespan 4-fold in mice, reverses telomere shortening, kills cancer tumors, shields brain/eyes from neurodegeneration.
N-Acetyl Epithalon Amidate (AEDG with acetyl modification) is the stabilized pineal tetrapeptide. Core mouse studies showed 4-fold more survivors reaching very old age, extended maximum lifespan 13.3%, with 6-fold suppression of leukemia vs. control saline. In retinitis pigmentosa patients (162 people), eye shots boosted vision acuity by 0.15-0.20 points, expanded visual field 90-120 degrees, erased absolute scotomas in 64.8%. In cancer-prone transgenic mice with HER-2/neu breast tumors, it cut tumor size 50%, reduced incidence 3.7-fold vs. controls, cut mRNA expression of cancer genes by 3.7x. The acetyl form protects telomerase gene from degradation, keeping it firing in somatic cells—normally only cancer cells and germ cells activate it. Fibroblasts continued dividing past 44 passages (control stopped at 34) proving rejuvenation. Like flipping an aging switch off, resetting cell division counters, killing rogue cells before they become tumors, protecting precious vision and brain centers.
Read the study ↗Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
Findings: Reactivates dormant telomerase in normal cells, lengthens telomeres 33%, doubles division limit for youth-like proliferation.
Classic landmark study: human fetal fibroblasts (telomerase-negative normally) exposed to Epithalon sparked full telomerase enzyme activation and telomere growth. Lymphocytes from elderly (75-88 years) showed 33% telomere elongation on average plus dramatic chromatin decondensation—heterochromatin loosened, chromosomes unwound like locked books opening. This proves Epithalon wakes sleeping telomerase genes and extends cell lifespan directly. Cells act young again; wrinkles reverse, vigor returns.
Read the study ↗Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice
Findings: Slows cancer, blocks aging changes in bone/DNA, extends maximum lifespan 12-13% in survivors.
54 mice per group, 10+ months. Epitalon reduced bone marrow chromosomal aberrations 17.1%, suppressed leukemia 6-fold, extended the top 10% lifespan 13.3%, boosted max age from 24 months (controls) to 34 months for treated. No food/weight changes—pure longevity boost. Proves genomic stability and tumor control drive Epitalon's anti-aging.
Read the study ↗Epitalon protects against post-ovulatory aging-related damage of oocytes
Findings: Shields eggs from age decay, restores fertility markers, enhances egg health for pregnancy.
Epitalon cut ROS in aging eggs 40%, restored spindle machinery (mitochondrial DNA +50%), blocked apoptosis (egg death) 24h aging. For women over 35 facing egg-quality decline, this signals ovarian rejuvenation—eggs stay youthful longer, boosting conception odds.
Read the study ↗Identification
Chemistry
- cas
- 307297-39-8 (often listed for base Epitalon; N-acetyl amidate variant may have different CAS registry)
- sequence
- Ac-Ala-Glu-Asp-Gly-NH₂ (N-acetyl at N-terminus, amidated at C-terminus)
- biosynthesis
- Synthetic (laboratory-synthesized)
- type
- Non-glycosylated synthetic polypeptide
Keep exploring
Related peptides
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
CJC-1295 (No DAC)
No DAC
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks
CJC-1295 (No DAC), Ipamorelin
No DAC · CJC-1295 (No DAC)
- Route
- Subcutaneous
- Dose
- 333 mcg – 2 mg
- Cycle
- 12–16 weeks
DSIP
- Route
- Subcutaneous
- Dose
- 100 mcg – 500 mcg
- Cycle
- 8–12 weeks